Jan 05, 2023 8:00am EST iBio Announces Issuance of U.S. Patent Covering AI-Engineered Epitope Discovery Engine
Dec 05, 2022 8:00am EST iBio® to Showcase the RubrYc® Discovery Engine During Poster Presentations at Antibody Engineering & Therapeutics Conference 2022
Sep 27, 2022 4:10pm EDT iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update
